Latest & greatest articles for heart failure

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on heart failure or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on heart failure and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for heart failure

121. Impact of metformin therapy on survival and functional capacity in the heart failure with ejection fraction (HFpEF) population: a systematic review and meta-analysis

Impact of metformin therapy on survival and functional capacity in the heart failure with ejection fraction (HFpEF) population: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

122. Efficacy and safety of Lingguizhugan decoction in the treatment of chronic heart failure: a systematic review and meta-analysis

Efficacy and safety of Lingguizhugan decoction in the treatment of chronic heart failure: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

123. A systematic review and meta-analysis, including dose-response relationships, between the pharmacological treatment of heart failure with reduced ejection fraction (stage C HFrEF) and the risks and consequences of hypotension

A systematic review and meta-analysis, including dose-response relationships, between the pharmacological treatment of heart failure with reduced ejection fraction (stage C HFrEF) and the risks and consequences of hypotension Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

124. A meta-analysis of antithrombotics for heart failure from randomized controlled trials

A meta-analysis of antithrombotics for heart failure from randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

125. Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial. Full Text available with Trip Pro

Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trial. Morphine is shown to relieve chronic breathlessness in chronic obstructive pulmonary disease. There are no definitive data in people with heart failure. We aimed to determine the effectiveness and cost-effectiveness of 12 weeks morphine therapy for the relief of chronic breathlessness in people with chronic heart failure compared with placebo.Parallel group, double-blind (...) .We could not answer our primary objectives due to inadequate power. However, we provide novel placebo-controlled medium-term benefit and safety data useful for clinical practice and future trial design. Morphine should only be prescribed in this population when other measures are unhelpful and with early management of side effects.© 2019 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

2019 ESC heart failure Controlled trial quality: predicted high

126. Which tools are available to help healthcare professionals to recognize palliative care needs in patients with chronic heart failure: a systematic review.

Which tools are available to help healthcare professionals to recognize palliative care needs in patients with chronic heart failure: a systematic review. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

127. Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): systematic review and meta-analysis of observational cohort studies conducted in large healthcare database

Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): systematic review and meta-analysis of observational cohort studies conducted in large healthcare database Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied

2019 PROSPERO

128. The efficacy of psychological interventions on health-related quality of life for heart failure patients with depression: a systematic review

The efficacy of psychological interventions on health-related quality of life for heart failure patients with depression: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

129. The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure - a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure - a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate

2019 PROSPERO

130. Efficacy and safety of 4 personal Chinese patent medicines in the treatment of chronic heart failure: a network meta-analysis

Efficacy and safety of 4 personal Chinese patent medicines in the treatment of chronic heart failure: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

131. Uric acid and risk of heart failure mortality: a dose-response meta-analysis of prospective cohort studies

Uric acid and risk of heart failure mortality: a dose-response meta-analysis of prospective cohort studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

132. Health literacy and outcomes among patients with heart failure: a systematic review and meta-analysis protocol

Health literacy and outcomes among patients with heart failure: a systematic review and meta-analysis protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

133. Relationship between serum chloride concentration and mortality risk in patients with heart failure: a meta-analysis

Relationship between serum chloride concentration and mortality risk in patients with heart failure: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

134. Clinical efficacy and safety of shenqi fuzheng injection for the treatment of chronic heart failure: a meta-analysis and systematic review

Clinical efficacy and safety of shenqi fuzheng injection for the treatment of chronic heart failure: a meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

135. Clinical efficacy and safety of danhong injection for the treatment of chronic heart failure: a meta-analysis and systematic review

Clinical efficacy and safety of danhong injection for the treatment of chronic heart failure: a meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

136. Chinese herbal preparations for chronic heart failure: a protocol for umbrella systematic review

Chinese herbal preparations for chronic heart failure: a protocol for umbrella systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

137. The diagnostic thresholds of N-terminal pro-B-type natriuretic peptide (NTproBNP) in acute heart failure: a systematic review and collaborative individual patient data meta-analysis

The diagnostic thresholds of N-terminal pro-B-type natriuretic peptide (NTproBNP) in acute heart failure: a systematic review and collaborative individual patient data meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

138. The effectiveness of interventions to support informal caregivers of patients with advanced heart failure receiving palliative care: a systematic review

The effectiveness of interventions to support informal caregivers of patients with advanced heart failure receiving palliative care: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

139. The effect of telemonitoring on self-care behaviors among community-dwelling adults with heart failure: a quantitative systematic review protocol

The effect of telemonitoring on self-care behaviors among community-dwelling adults with heart failure: a quantitative systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

140. The effect of ivabradine on heart rate and left ventricular function in heart failure: a meta-analysis of heart failure patients with reduced versus preserved left ventricular ejection fraction

The effect of ivabradine on heart rate and left ventricular function in heart failure: a meta-analysis of heart failure patients with reduced versus preserved left ventricular ejection fraction Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO